Particle yields in heavy ion collisions and the influence of strong magnetic fields

It is expected that the magnetic field in the surface of magnetars do not exceed $10^{15}$ G. However, in heavy ion collisions, this value is expected to be much higher. We investigate the effects of a magnetic fields varying from $10^{18}$, to $10^{20}$ G in strange matter (composed of $u$, $d$ and $s$ quarks). We model matter as a free gas of baryons and mesons under the influence of an external magnetic field. We study the effects of such strong fields through a $\chi^2$ fit to some data sets of the STAR experiment. For this purpose we solve the Dirac, Rarita-Schwinger, Klein-Gordon and Proca equations subject to magnetic fields in order to obtain the energy expressions and the degeneracy for spin 1/2, spin 3/2, spin 0 and spin 1 particles, respectively. Our results show that a field of the order of $10^{19}$ G produces an improved fitting to the experimental data as compared to the calculations without magnetic field.Comment: 20 pages, 16 figures, 4 table

Participatory design, beyond the local

This workshop aims at stimulating and opening a debate around the capacity of Participatory Design (PD) and other co-design approaches to deliver outcomes and methodologies that can have an impact and value for reuse well beyond the local context in which they were originally developed. This will be achieved by stimulating the submission of position papers by researchers from the PD community and beyond.These papers will be discussed during the workshop in order to identify challenges, obstacles but also potentials for scaling up PD processes and results from the local to the global.</p

The perceived severity of a disease and the impact of the vocabulary used to convey information: using Rasch scaling in a simulated oncological scenario.

Background: Healthcare staff should be aware of the importance that patients may attach to the words that are used to convey information. This is relevant in terms of the patients\u2019 understanding. Modeling how people understand the information conveyed in a medical context may help health practitioners to better appreciate the patients\u2019 approach. Purpose: 1) Analyze the participants\u2019 self-reported perception of the type of information provided in an oncological scenario in terms of three dimensions: impairment to their health, risks associated with the disease itself and commitment required to undergo the treatment; and 2) show the benefits of using Rasch scaling for the analysis of the data. Starting from a survey, Rasch scaling produces a unidimensional logit-interval scale relating to the extent to which each item conveys a latent dimension. These were related to structure, in particular concerning communication by means of opposite vs. unipolar language. Subjects and methods: The participants rated 82 items of information in a questionnaire regarding their perception of impairment to their health (H) and the risks (R) and commitment relating to the treatment prescribed (T). Results: The scaling produced an item bank for healthcare staff to consult in order to estimate the importance the recipient would be likely to attach to the vocabulary used and the likely impact of the information in terms of the patient\u2019s condition. Furthermore, the use of opposites was generally associated with a clearer impression of whether the information given was generally only very negative or slightly negative, whereas \u2018neutral\u2019 information was often perceived as being very negative. Actual findings: Is possible to estimate people\u2019s understanding more precisely (in terms of H, R and T) which can help healthcare practitioners to modulate the way they convey information. Limitations: The participants in the study were healthy volunteers and the context was simulated

The Rarita-Schwinger Particles Under de Influence of Strong Magnetic Fields

In this work, we calculate the solutions of the Rarita-Schwinger equation with the inclusion of the eletromagnetic interaction. Our gauge and coupling prescription choices lead to Dirac-type solutions. One of the consequences of our results are the Landau level occupation of particles, quite different from the usual spin 1/2 particle system occupation numbers.Comment: 12 page

Effect of meteorological and agronomic factors on maize grain contamination by fumonisin

Fumonisins are toxic secondary metabolites produced by fungi such as F.verticilloides. Maize is commonly colonized by several spoilage fungi both in pre- and post-harvest conditions. Field infection prevention is the best solution to contain contamination, using practices aimed at restricting plant stress and limiting the propagation of the disease. This work is focused on understanding the effect of environmental factors on the production of fumonisins in Friuli Venezia Giulia (NE Italy) on maize crops. The analysis has been performed on a dataset covering a period of 14 years (from 2000 to 2013), recording fumonisins contamination and daily meteorological data (air temperature, RH, Rain, Wind speed) for 13 different drying plants and for three different harvest times (early, medium and late). The drying plants collect grain production from an area of about 70.000-100.000 ha. Data were analyzed by full factorial ANOVA and a multiple regression approach was performed using STATA and SEMoLa software. ANOVA test pointed out a significant effect of factors \u201cyear\u201d and \u201charvest time\u201d (p<0.01) for fumonisin content. Instead, location had no significant effect. The best regression model (R2=0. 65, 2... observation) detected a significant correlation between fumonisin concentration and meteorological data in the period from 15th to 31st July. High fumonisin contents were positively correlated with daily thermal excursion, minimum temperature and wet conditions in this period. Silk drying and harvest time resulted as the key factors to contain and study fumonisins contamination in maize. Results will be used to implement a more complex dynamic model

Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic

YesContext: Urinary biomarkers are promising as simple alternatives to cystoscopy for the diagnosis of de novo and recurrent bladder cancer. Objective: To identify a highly sensitive and specific biomarker candidate set with potential clinical utility in bladder cancer. Materials and methods: Urinary biomarkers concentrations were determined by ELISA. The performance of individual markers and marker combinations was assessed using ROC analysis. Results: A 5-biomarker panel (IL8, MMP9, VEGFA, PTGS2 and EN2) was defined from the candidate set. Discussion and conclusion: This panel showed a better overall performance than the best individual marker. Further validation studies are needed to evaluate its clinical utility in bladder cancer.This work has been supported in part by the European Commission Program DIPROMON - HEALTH-F5-2012-306157-2: Development of an integrated protein- and cell-based device for non-invasive diagnostics in the urogenital tract

A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma

Presence of the Human Herpesvirus 8 (HHV8) genome has been reported in the bone marrow of multiple myeloma (MM) patients. So far, serological studies of HHV8 and MM have been inconsistent but have not included prospective epidemiological studies. We evaluated whether HHV8 infection is associated with increased risk for MM in a prospective population-based study of 39 000 Finnish subjects who donated serum samples in the period 1968–72. Serum samples from 47 subjects who developed MM during a 23-year follow-up and 224 age, area of residence and sex-matched subjects who remained healthy over a similar follow-up period were evaluated for HHV8 antibodies at enrolment, as assayed both with an immunofluorescence assay (IFA) for lytic and latent HHV8 antigens and by Western blot (WB) with three recombinant HHV8 proteins (ORFs 65, 73 and K8.1A). HHV8 seropositivity for at least one HHV8 protein on WB was found in 7% of the Finnish population and was not associated with the risk of developing MM (Relative Risk (RR) = 0.89, Confidence Interval (CI): 0.25–3.25). HHV8 seropositivity for lytic and latent antigens in the IFA was found in 16% and 0.4% of the Finnish population and tended to associate with risk of MM (RR = 2.02, CI: 0.94–4.33 and RR = 10.00, CI: 0.91–110.29, respectively). In conclusion, no statistically significant evidence for an association between HHV8 infection and the risk of future MM was found. © 2001 Cancer Research Campaign http://www.bjcancer.co

Use of complementary and alternative medicine (CAM) in cancer patients. An italian multicenter survey

INTRODUCTION: Complementary and Alternative Medicine (CAM) include a wide range of products (herbs, vitamins, minerals, and probiotics) and medical practices, developed outside of the mainstream Western medicine. Patients with cancer are more likely to resort to CAM first or then in their disease history; the potential side effects as well as the costs of such practices are largely underestimated. PATIENTS AND METHOD: We conducted a descriptive survey in five Italian hospitals involving 468 patients with different malignancies. The survey consisted of a forty-two question questionnaire, patients were eligible if they were Italian-speaking and receiving an anticancer treatment at the time of the survey or had received an anticancer treatment no more than three years before participating in the survey. RESULTS: Of our patients, 48.9% said they use or have recently used CAM. The univariate analysis showed that female gender, high education, receiving treatment in a highly specialized institute and receiving chemotherapy are associated with CAM use; at the multivariate analysis high education (Odds Ratio, (OR): 1.96 95% Confidence Interval, CI, 1.27-3.05) and receiving treatment in a specialized cancer center (OR: 2.75 95% CI, 1.53-4.94) were confirmed as risk factors for CAM use. CONCLUSION: Roughly half of our patients receiving treatment for cancer use CAM. It is necessary that health professional explore the use of CAM with their cancer patients, educate them about potentially beneficial therapies in light of the limited available evidence of effectiveness, and work towards an integrated model of health-care provision